Zika had once been considered harmless, because about 80% of people who are infected show no symptoms. But alarms were sounded in 2015, when Brazilian officials suspected Zika as the cause of an outbreak of microcephaly brain malformation in babies. Public health . . . Continue reading →
A five-year government supported study, “Affective Neuroscience of Pediatric Bipolar Disorder,” was halted after parents complained to the University of Illinois in Chicago. According to documents obtained by ProPublica Illinois, Dr. Mani Pavuluri, a prominent psychiatrist who had founded the Pediatric Mood . . . Continue reading →
"For patients, navigating the debate can be difficult because doctors, patient advocacy groups and manufacturers often endorse positions that are in their economic self-interest." The New York Times Continue reading →
America’s profit-driven medical paradigm overdiagnoses illness and garners profits from unnecessary treatment. Continue reading →
A commentary in the April 2007 issue of HARVAD magazine, AHRP board member, Stefan Kruszeuski, MD, urges his colleagues to abandon psychiatry’s diagnostic and therapeutic reductionism.
Doctor Tells Pfizer Sales Rep who promoted Celebrex: “Have You No Shame?” Sun, 26 Dec 2004 An opinion piece by Dr. Marc Siegel, an internist and professor at New York University School of Medicine, expresses the anger and dismay many physicians in . . . Continue reading →
TONIGHT ABC “PRIMETIME LIVE” INVESTIGATION reveals evidence that drug makers suppressed antidepressant info Thu, 9 Dec 2004 At least 100 children have committed suicide while on an SSRI antidepressant, hundreds more have attempted suicide. Tonight at 10:00 PM, ABC Prime Time Live . . . Continue reading →
Spitzer Expands drug Probe: Johnson & Johnson / New FDA analysis Confirms SSRI Risks to Kids – WSJ Thu, 5 Aug 2004 A front page article in The Wall Street Journal reports that a second FDA analysis of 25 clinical trials of . . . Continue reading →
GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety issues are beginning to have a financial impact. Dow Jones reports: “GlaxoSmithKline PLC said its net income fell 6% in the fourth quarter, hurt by . . . Continue reading →
“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004 Forest Laboratories, manufacturer of the antidepressant, Celexa / Lexapro, is the latest manufacturer to issue warnings (April 2004) about the possibility that “patients with major . . . Continue reading →
http://www.illinoisleader.com/opinion/opinionview.asp?c=17908 GUEST OPINION: Maybe legislators should be mentally evaluated, too Friday, July 23, 2004 – by Karen Hayes, associate director of Concerned Women for America-Illinois If Illinois’ Children’s Mental Health Partnership Preliminary Plan goes into effect as planned next year, standardized academic . . . Continue reading →
Statin-Cholesterol Guidelines–Industry influenced? Wed, 14 Jul 2004 Scientific journal editors are scrambling about how to react to bad publicity emanating from public disclosure that the scientific reports they have published are likely to be biased because the authors’ had financial ties to . . . Continue reading →
